PubMed Health. A service of the National Library of Medicine, National Institutes of Health.

National Collaborating Centre for Women's and Children's Health (UK). Antibiotics for Early-Onset Neonatal Infection: Antibiotics for the Prevention and Treatment of Early-Onset Neonatal Infection. London: RCOG Press; 2012 Aug. (NICE Clinical Guidelines, No. 149.)

Appendix BDeclarations of interest

All GDG members’ interests were recorded on declaration forms provided by NICE. The form covered consultancies, fee-paid work, shareholdings, fellowships and support from the healthcare industry. GDG members’ interests are listed in this section. No material conflicts of interest were identified.

This appendix includes all interests declared on or before 14 August 2012.

Table B.1GDG members’ declarations of interest

GDG memberInterest
Gareth BarrettNo interests declared
Neil A CaldwellPersonal non-pecuniary

Member of the paediatric formulary committee for the British National Formulary for children (BNFc) from March 2011
Jim GrayPersonal pecuniary

Conference expenses from Glaxo Smith Kline; author’s fee from Archives of Disease in Childhood for leading article about antibiotic resistance in neonates

Non-personal pecuniary

Principal applicant for funding from Pfizer Anti-Infectives Research Foundation (treatment of Gram positive bacterial infections in children; study not funded)

Personal non-pecuniary

Adviser to Philips AVENT on sterilisers for baby feeding equipment; adviser to British National Formulary for children (BNFc); associate editor, Journal of Pediatric Infectious Diseases; paediatric section editor, International Journal of Antimicrobial Agents; assistant editor, Journal of Hospital Infection; member of National Institute of Health Research (NIHR) Evaluation, Trials and Studies Coordinating Centre (NETSCC) health technology assessment pharmaceutical panel
Paul HeathPersonal pecuniary

Consult for Novartis Vaccines in relation to development of a group B streptococcus (GBS) vaccine

Non-personal pecuniary

Funding from Action Medical Research (study on gentamicin dosing in neonatal infections), the European Commission (study of meropenem in neonatal sepsis and meningitis), the Gilead Foundation (audit of neonatal fungal infection) and the Meningitis Research Foundation (study of neonatal meningitis)

Personal non-pecuniary

Member of the Royal College of Obstetricians and Gynaecologists (RCOG) prevention of group B streptococcus guideline development group; author of editorial on antibiotic use in neonates to appear in Archives of Disease in Childhood
Vanessa HodgeNo interests declared
David HoweNo interests declared
Marie HubbardPersonal pecuniary

Draeger Nursing Scholarship (study of prescribing practice in early-onset neonatal infection)
Jane PlumbPersonal non-pecuniary

Spokesperson for Group B Strep Support (GBSS), including views on prevention of group B streptococcal infection in babies
Farrah PradhanNo interests declared
Aung SoePersonal pecuniary

Member of bronchitis pathway development group for Abbott (not related to neonatal antibiotics)

Non-personal pecuniary

Hospital department is involved in a staphylococcal monoclonal antibody study (source of funding not known by AS)

Personal non-pecuniary

Member of National Patient Safety Agency and Royal College of Paediatrics and Child Health expert working group on safer practice in neonatology (use of gentamicin)
Mark TurnerNon-personal pecuniary

Chief investigator for projects funded by Johnson and Johnson (pharmacokinetic study of doripenem) and Roche (oseltamivir phosphate in premature babies); lead scientist for projects funded by the European Commission (pharmacokinetic study of ciprofloxacin, paediatric investigation plans for ciprofloxacin and fluconazole, and discussion of azithromycin, including a request for scientific advice from the European Medicines Agency); co-investigator in a project funded by Action Medical Research about gentamicin dosing in neonates; department receives funding (not related to neonatal antibiotics) from Actavis, Ferring Pharmaceuticals, Janssen-Cilag, Johnson and Johnson, Monica Healthcare Limited, Orbis UK, Pfizer and Quay Pharma; department receives funding for one day consultancy from Novartis Vaccines (related to safety assessment for a vaccine to group B streptococcus)
Miles WagstaffNo interests declared

Table B.2NCC-WCH staff members’ declarations of interest

NCC-WCH staffInterest
Khalid AshfaqNo interests declared
Shona Burman-RoyNo interests declared
Katherine CullenNo interests declared
Anwar JilaniNo interests declared
Rosalind LaiNo interests declared
Moira MugglestoneNo interests declared
M Stephen MurphyNo interests declared
Leo NhereraNo interests declared
Cristina VisintinNo interests declared

Table B.3External advisors’ declarations of interest

External advisorInterest
Alison Bedford RussellNo interests declared
Copyright © 2012, National Collaborating Centre for Women’s and Children’s Health.

No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

Cover of Antibiotics for Early-Onset Neonatal Infection
Antibiotics for Early-Onset Neonatal Infection: Antibiotics for the Prevention and Treatment of Early-Onset Neonatal Infection.
NICE Clinical Guidelines, No. 149.
National Collaborating Centre for Women's and Children's Health (UK).
London: RCOG Press; 2012 Aug.

PubMed Health Blog...

read all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...